SXTC

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SXTC

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/05	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2024/10/26	01:19	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2024/10/23	05:51	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2024/10/16	05:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2024/10/08	05:15	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2024/08/14	05:15	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2024/08/01	05:15	Edgar (US Regulatory)	Form NT 20-F - Notification of inability to timely file Form 20-F	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2024/05/15	05:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2024/01/12	06:31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/10/27	05:05	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/10/04	21:30	GlobeNewswire Inc.	China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/08/01	05:15	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/05/20	06:17	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/05/10	21:00	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/03/30	03:20	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/03/30	02:50	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/03/27	19:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/03/01	06:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/02/25	07:20	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/02/14	06:29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/12/23	20:05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/11/07	22:00	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/10/12	21:46	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/09/27	21:01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/07/19	00:02	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/05/19	01:30	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/05/14	05:09	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/05/12	05:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/03/25	05:32	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/03/17	05:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc